Publications by authors named "Massimo Marignani"

Claim this Profile
D
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis.
Antonio De Vincentis, Javier Ampuero, Francesca Terracciani, Daphne D'Amato, Alessio Gerussi, Massimo Marignani

Clin Gastroenterol Hepatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study.
Filomena Morisco, Alessandro Federico, Massimo Marignani, Flavia L Lombardo, Valentina Cossiga

Viruses· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib.
Maurizio Biselli, Nicola Reggidori, Massimo Iavarone, Matteo Renzulli, Lorenzo Lani, Massimo Marignani

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication.
Romina Salpini, Lorenzo Piermatteo, Giulia Torre, Stefano D'Anna, Sohaib Khan, Massimo Marignani

Int J Infect Dis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies.
Lorenzo Piermatteo, Stefano D'Anna, Ada Bertoli, Maria Bellocchi, Luca Carioti, Massimo Marignani

Emerg Microbes Infect· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumococcal vaccination status among cirrhotic patients in Italy: a neglected topic.
Tommaso Stroffolini, Alessia Ciancio, Alessandro Federico, Rosa G Benigno, Guido Colloredo, Massimo Marignani

Eur J Clin Microbiol Infect Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 vaccination among cirrhotics in Italy: High coverage and effectiveness of 3 doses versus 2 in preventing breakthrough infection and hospitalization.
Tommaso Stroffolini, Alessia Ciancio, Alessandro Federico, Rosa G Benigno, Guido Colloredo, Massimo Marignani

Dig Liver Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities management.
Michela Roberto, Martina Panebianco, Anna Maria Aschelter, Dorelsa Buccilli, Carmen Cantisani, Massimo Marignani

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 emergency: Changes in quality of life perception in patients with chronic liver disease-An Italian single-centre study.
Alessandra Zannella, Silvia Fanella, Massimo Marignani, Paola Begini

World J Hepatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B vaccine coverage and risk factors for lack of vaccination in subjects with HBsAg negative liver cirrhosis in Italy: still, much work should be done.
Tommaso Stroffolini, Anna Lombardi, Alessia Ciancio, Rosanna Fontana, Guido Colloredo, Massimo Marignani

Dig Liver Dis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective Study.
Filomena Morisco, Alessandro Federico, Massimo Marignani, Mariarita Cannavò, Giuseppina Pontillo

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular Carcinoma Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE): Outcome Analysis Using a Model Based On Pre-Treatment CT Texture Features.
Marcello Andrea Tipaldi, Edoardo Ronconi, Elena Lucertini, Miltiadis Krokidis, Marta Zerunian, Massimo Marignani

Diagnostics (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low influenza vaccination coverage in subjects with liver cirrhosis. An alert waiting for winter season 2020-2021 during the COVID-19 pandemic.
Tommaso Stroffolini, Anna Lombardi, Alessia Ciancio, Grazia A Niro, Guido Colloredo, Massimo Marignani

J Med Virol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels , hinder HBsAg secretion and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection.
Romina Salpini, Arianna Battisti, Lorenzo Piermatteo, Luca Carioti, Olympia E Anastasiou, Massimo Marignani

Emerg Microbes Infect· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained virological response in patients with HCV treated with daclatasvir plus sofosbuvir, with or without ribavirin: a large, field-practice study.
Rodolfo Sacco, Vincenzo Messina, Umberto Vespasiani Gentilucci, Luigi Elio Adinolfi, Antonio Ascione, Massimo Marignani

Drugs Context· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Sarcopenia and Body Composition With Short-term Outcomes After Liver Resection for Malignant Tumors.
Giammauro Berardi, Giulio Antonelli, Marco Colasanti, Roberto Meniconi, Nicola Guglielmo, Massimo Marignani

JAMA Surg· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in Italy.
Marco Canzoni, Massimo Marignani, Maria Laura Sorgi, Paola Begini, Michela Ileen Biondo

Microorganisms· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients.
Adriano Pellicelli, Vincenzo Messina, Valerio Giannelli, Marco Distefano, Valeria Pace Palitti, Massimo Marignani

Gut Liver· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro.
Romina Salpini, Lorenzo Piermatteo, Arianna Battisti, Luna Colagrossi, Marianna Aragri, Massimo Marignani

Viruses· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematological Malignancies and HBV Reactivation Risk: Suggestions for Clinical Management.
Alessandra Zannella, Massimo Marignani, Paola Begini

Viruses· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection.
Romina Salpini, Arianna Battisti, Luna Colagrossi, Domenico Di Carlo, Lavinia Fabeni, Massimo Marignani

J Viral Hepat· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study.
Alessandro Vitale, Fabio Farinati, Giulia Noaro, Patrizia Burra, Timothy M Pawlik, Massimo Marignani

Hepatology· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment.
Giulio Antonelli, Elia Gigante, Massimo Iavarone, Paola Begini, Angelo Sangiovanni, Massimo Marignani

United European Gastroenterol J· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets.
Luna Colagrossi, Romina Salpini, Rossana Scutari, Luca Carioti, Arianna Battisti, Massimo Marignani

Viruses· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study.
Mauro Borzio, Elena Dionigi, Angelo Rossini, Massimo Marignani, Rodolfo Sacco

Hepatology· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis